Northborne Partners

MINNEAPOLIS, MN, JANUARY 21, 2022 - Northborne Partners acted as the exclusive financial advisor to Transplant Connect, Inc. (“Transplant Connect”) in connection with an investment received from InVita Healthcare Technologies (“InVita”), a portfolio company of The Riverside Company. The transaction closed on December 28, 2021; financial terms were not disclosed.

Transplant Connect is the world's leading provider of human biologics (organ, tissue, eye, placenta, etc.) donation and transplantation software. Its award-winning, cloud-based iTransplant℠ Donation and Transplantation Platform enables nearly 75% of all deceased organ donation in the U.S. and is used by more than 12,500 medical professionals at over 100 donation and transplantation agencies all over the world. The business was founded in 2003 by its Chairman and CEO, John Piano.

InVita Healthcare Technologies provides chain of custody software technologies for complex medical environments including blood and plasma, implant management and forensic and community care environments. Its solutions optimize supply chains, sample tracking, and visibility across blood and plasma operations, the tissue and implant lifecycle, and environments spanning DNA and forensics. The investment in Transplant Connect was highly strategic to InVita, expanding its product portfolio and customer base within the donation-transplantation ecosystem.

Paul Jevnick, Managing Director at Northborne said, “The business built by John Piano and his team over the past two decades has made significant contributions in saving and enhancing countless lives across the globe. It was a privilege to help Transplant Connect find the ideal partner to the accelerate its impact.”

“We are truly excited by this investment from InVita,” said John Piano, Founder, Chairman and CEO, Transplant Connect. “Through this investment, we’ll be able to expand vital resources and capabilities and meaningfully grow our innovation – allowing us to further connect the donation-transplant ecosystem.” Regarding Northborne’s involvement in the transaction, John Piano said, “The Northborne team was responsive, professional, dedicated and insightful. I couldn’t be more pleased with the outcome, as well as with the advice and guidance they provided along the way. Northborne was an invaluable partner from start to finish – they had our back all the way to closing.”

About Northborne Partners

Northborne Partners is a preeminent middle market investment banking firm focused on providing M&A advisory services to companies in the food & consumer, healthcare and industrials sectors, among others. It focuses on advising private business owners in the sale of their companies and has decades of experience sitting across the table from the most seasoned strategic and private equity buyers in the world. Northborne Partners is headquartered in Minneapolis, MN. For more information, please visit www.northborne.com.

About Transplant Connect

Founded in 2004 as a mission-driven medical software company, Transplant Connect is the world’s leading provider of human biologics (organ, tissue, eye, placenta and other) donation and transplantation software. Included in the company’s growing suite of solutions are iTransplant℠, a secure cloud-based platform for clinical management, communications, analytics and logistics, and iReferral℠, the first and only automated donor referral technology available to hospitals, medical examiners/coroners, organ procurement organizations, tissue banks and eye banks. For more information, please visit www.transplantconnect.com.

About InVita Healthcare Technologies

InVita provides chain of custody software technologies for complex medical, forensic and community care environments. InVita’s solutions optimize supply chains, sample tracking, and visibility across blood and plasma operations, the tissue and implant lifecycle, and environments spanning DNA and forensics. InVita’s solutions support increased compliance and cost control, reduced risk, and improved patient and public safety outcomes. For more information, please visit www.invitahealth.com.